Item 7.01 Regulation FD Disclosure.
On January 4, 2023, Replimune Group, Inc. ("Replimune") issued a press release
announcing the appointment of Chris Sarchi as its Chief Commercial Officer and,
in connection therewith, the appointment of Sushil Patel, Replimune's previous
Chief Commercial Officer, to a newly formed position of Chief Strategy Officer,
effective immediately. A copy of the press release is furnished herewith as
Exhibit 99.1.
The information contained in this Item 7.01 and in the accompanying Exhibit 99.1
shall not be incorporated by reference into any filing of Replimune, whether
made before or after the date hereof, regardless of any general incorporation
language in such filing, unless expressly incorporated by specific reference to
such filing. The information in this Item 7.01 and the accompanying Exhibit 99.1
shall not be deemed to be "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended.
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 News Release, dated January 4, 2023, announcing the appointment of
Chris Sarchi and Sushil Patel as Replimune's Chief Commercial Officer
and Chief Strategy Officer, respectfully.
104 Cover page interactive data file (formatted as Inline XBRL)
© Edgar Online, source Glimpses